a public good project by the
Synthesis
Company
of California

© 2026

Philip J. Barter | doi.page

0 works0 citations0 h-index

Philip J. Barter

Publications by Year

Research Areas

Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Cancer, Lipids, and Metabolism, Cholesterol and Lipid Metabolism, Peroxisome Proliferator-Activated Receptors

Most-Cited Works

→ Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease(2005)3,485 cited
→ Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial(2005)3,260 cited
→ Effects of Torcetrapib in Patients at High Risk for Coronary Events(2007)3,113 cited
→ New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk(2010)2,224 cited
→ Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome(2012)2,011 cited
→ Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity(2020)1,795 cited

→ HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events(2007)

1,611 cited

→ Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement(2019)1,407 cited

→ Antiinflammatory Properties of HDL(2004)1,351 cited

→ Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk(2020)950 cited